Does APIXABAN Cause Transfusion? 561 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 561 reports of Transfusion have been filed in association with APIXABAN (ELIQUIS). This represents 0.4% of all adverse event reports for APIXABAN.
561
Reports of Transfusion with APIXABAN
0.4%
of all APIXABAN reports
82
Deaths
436
Hospitalizations
How Dangerous Is Transfusion From APIXABAN?
Of the 561 reports, 82 (14.6%) resulted in death, 436 (77.7%) required hospitalization, and 121 (21.6%) were considered life-threatening.
Is Transfusion Listed in the Official Label?
Yes, Transfusion is listed as a known adverse reaction in the official FDA drug label for APIXABAN.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Transfusion?
MACITENTAN (858)
VENETOCLAX (793)
ECULIZUMAB (454)
WARFARIN (377)
SELEXIPAG (289)
ADALIMUMAB (264)
AMBRISENTAN (244)
CEDAZURIDINE\DECITABINE (229)
EPOPROSTENOL (225)
IBRUTINIB (212)
Which APIXABAN Alternatives Have Lower Transfusion Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ